Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Rachel Ruskin"'
Publikováno v:
Gynecologic Oncology Reports, Vol 53, Iss , Pp 101386- (2024)
Externí odkaz:
https://doaj.org/article/4f79edc2a03e4249adad2964f1e2ed13
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp S24- (2023)
Objectives: Burnout in medicine is a growing crisis, and SGO has identified combatting burnout as a priority. The estimated prevalence of burnout is almost 90% among Gyn-Oncology fellows and 50% among Ob/Gyn residents. Most wellness initiatives focus
Externí odkaz:
https://doaj.org/article/836a0a7ce8f64499ba6e8975f5feddc7
Autor:
M. Greenwade, A. Crim, Rachel Ruskin, M. Rowland, Kai Ding, Adam Walter, Justin D. Dvorak, J. Gillen, Kathleen N. Moore, Camille C. Gunderson
Publikováno v:
Gynecologic Oncology. 146:268-272
Intraperitoneal (IP) chemotherapy (CT) for treatment of epithelial ovarian cancer (EOC) has been shown to provide a substantial OS advantage. This study aims to compare the toxicity and benefits of IP CT in patients ≥70 with those70.We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d584aece1a50800e738036bb5ca345f
https://doi.org/10.1016/j.ygyno.2017.05.032
https://doi.org/10.1016/j.ygyno.2017.05.032
Autor:
A.K. Crim, Rachel Ruskin, M. Rowland, Kathleen N. Moore, Camille C. Gunderson, Kai Ding, J. Gillen, Adam Walter, Emily White, M. Greenwade
Publikováno v:
Gynecologic Oncology. 145:32-36
Increasing age has been correlated with shorter survival in ovarian cancer patients, a finding attributed to diminished tolerance of standard therapy. Elderly patients, however, are less likely to enroll on clinical trials; thus, limited data exists
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6ffacca6c0d01e5023eb1d7653a4df
https://doi.org/10.1016/j.ygyno.2016.12.023
https://doi.org/10.1016/j.ygyno.2016.12.023
Autor:
Rachel Ruskin, Joan L. Walker, M. Rowland, Kathleen N. Moore, T. Castellano, Kai Ding, L. Driskill
Publikováno v:
Gynecologic Oncology. 156:e22-e23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b888342e86eab18705ab66dc02b2eae
https://doi.org/10.1016/j.ygyno.2019.11.077
https://doi.org/10.1016/j.ygyno.2019.11.077
Publikováno v:
Gynecologic oncology. 156(2)
Purpose The impact of gynecologic cancer on health-related quality of life (HRQOL) is not fully understood. To our knowledge, this is the first longitudinal study to measure HRQOL changes from before to after gynecologic cancer diagnosis in older wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf60e6eeed057ca6c67e1d114e74bd62
https://pubmed.ncbi.nlm.nih.gov/31806400
https://pubmed.ncbi.nlm.nih.gov/31806400
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 28(10)
Health-related quality of life (HRQOL) is an important prognostic factor in cancer patients. To date, no other studies have assessed the association between HRQOL measured before diagnosis and survival in older women with endometrial cancer.The Surve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cbfe9fb64a1acb8131d80386ca05e88f
https://pubmed.ncbi.nlm.nih.gov/32008090
https://pubmed.ncbi.nlm.nih.gov/32008090
Publikováno v:
Journal of geriatric oncology. 11(5)
This study aims to assess factors associated with depressive symptoms in older women with gynecologic cancers and to examine the association of depression with health-related quality of life (HRQOL).Women aged 65 and older previously diagnosed with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb150f5a1ffab70a772f327592e25c41
https://pubmed.ncbi.nlm.nih.gov/31668948
https://pubmed.ncbi.nlm.nih.gov/31668948
Autor:
Scott McMeekin, Anil K. Sood, Danny N. Dhanasekaran, Akhil Srivastava, Rachel Ruskin, Justyna Filant, Rajagopal Ramesh, Katherine M. Moxley, Anish Babu
Publikováno v:
Journal of Biomedical Nanotechnology. 12:1159-1173
The bottleneck in current vector-based cancer therapy is the targeted and controlled release of therapeutics in tumors. Exosomes are submicron-sized vesicles that are secreted by all cell types and are involved in communication and transportation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f112a54991e6080aefeea162a335d1
https://doi.org/10.1166/jbn.2016.2205
https://doi.org/10.1166/jbn.2016.2205
Publikováno v:
Gynecologic Oncology. 159:e26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9671337922721246fc9bda0273411d2c
https://doi.org/10.1016/j.ygyno.2020.07.067
https://doi.org/10.1016/j.ygyno.2020.07.067